La référé procédural entre au Code de procédure civile. Un texte bienvenue... mais encore insuffisant

2009/08/31 by Jonathan Price, Victoria Cole, Guy M. Goodwin +1 · 30 citations
Social Sciences · #Legal processes and jurisprudence #Criminal Law and Evidence #Comparative and International Law Studies

paper · pdf · doi:10.1192/bjp.bp.108.051110

Abstract

Emotional side-effects of SSRIs are a robust phenomenon, prominent in some people's thoughts about their medication, having a demonstrable impact on their functioning and playing a role in their decision-making about antidepressant adherence.

Cited by

• Positive affect treatment for depression and anxiety: A randomized clinical trial for a core feature of anhedonia.
• Positive affect treatment targets reward sensitivity: A randomized controlled trial.
• Apathy associated with antidepressant drugs: a systematic review
• Patient-Centered Perspectives on Antidepressant Use
• Antidepressant [wikipedia]
• Don't worry, be happy: positive affect and reduced 10-year incident coronary heart disease: the Canadian Nova Scotia Health Survey. [europepmc]
• Reconsidering anhedonia in depression: lessons from translational neuroscience. [europepmc]
• Neural correlates of antidepressant-related sexual dysfunction: a placebo-controlled fMRI study on healthy males under subchronic paroxetine and bupropion. [europepmc]
• Modulation of frontostriatal interaction aligns with reduced primary reward processing under serotonergic drugs. [europepmc]
• Disrupted-in-schizophrenia-1 Gln31Leu polymorphism results in social anhedonia associated with monoaminergic imbalance and reduction of CREB and β-arrestin-1,2 in the nucleus accumbens in a mouse model of depression. [europepmc]
• Reduced reward learning predicts outcome in major depressive disorder. [europepmc]
• Moment-to-moment transfer of positive emotions in daily life predicts future course of depression in both general population and patient samples. [europepmc]
• Neural correlates of change in major depressive disorder anhedonia following open-label ketamine. [europepmc]
• Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports. [europepmc]
• Down-regulation of cholinergic signaling in the habenula induces anhedonia-like behavior. [europepmc]
• Cortico-Striatal-Thalamic Loop Circuits of the Orbitofrontal Cortex: Promising Therapeutic Targets in Psychiatric Illness. [europepmc]
• Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression. [europepmc]
• 5-HT2C receptor blockade reverses SSRI-associated basal ganglia dysfunction and potentiates therapeutic efficacy. [europepmc]
• Circuit Mechanisms of Reward, Anhedonia, and Depression. [europepmc]
• Dorsal raphe serotonin neurons inhibit operant responding for reward via inputs to the ventral tegmental area but not the nucleus accumbens: evidence from studies combining optogenetic stimulation and serotonin reuptake inhibition. [europepmc]
• Addiction, Anhedonia, and Comorbid Mood Disorder. A Narrative Review. [europepmc]
• Anhedonia as a key clinical feature in the maintenance and treatment of opioid use disorder. [europepmc]
• Characterizing anhedonia: A systematic review of neuroimaging across the subtypes of reward processing deficits in depression. [europepmc]
• Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder. [europepmc]
• Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders. [europepmc]
• Progress and challenges in research of the mechanisms of anhedonia in major depressive disorder. [europepmc]
• The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world. [europepmc]
• Reward-related predictors of symptom change in behavioral activation therapy for anhedonic adolescents: a multimodal approach. [europepmc]
• Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment. [europepmc]
• Positive affect treatment targets reward sensitivity: A randomized controlled trial. [europepmc]

Related

• La surmédicalisation de la dépression : science, marketing et biopouvoir
• Étude de l'observance Thérapeutique par l'application de l'Échelle de Morisky Green sur 328 déprimés vus au Service d'Addictologie et d'Hygiène Mentale d'Abidjan
• La prescription des psychotropes en période périnatale
• Evolution de l’observance thérapeutique et facteurs associés chez les patients déprimes suivis en ambulatoire
• REPÉRAGE ET ÉVALUATION DU RISQUE SUICIDAIRE EN MÉDECINE GÉNÉRALE